General Decolonization With Octenisan® Set Before Elective Orthopedic Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

1,086

Participants

Timeline

Start Date

February 27, 2023

Primary Completion Date

November 28, 2024

Study Completion Date

February 20, 2025

Conditions
Elective SurgeryHigh RiskPrevention of Surgical Site InfectionsRandomized-controlled Trial
Interventions
DRUG

Whole Body and nasal decolonization with octenidin (Octenisan Set)

"Octenidin body lotion once a day during the five consecutive days preceding the elective orthopedic surgery, including for the hair.~Octenidin nasal creme 2-3 times a day in both nasal orifices during the same period"

BEHAVIORAL

Questionnaire for study participants immediately after the decolonization

"A questionnaire in GErman language will be handed out to decolonized patients with five questions: Practical difficulties of decolonization, the completeness of scheduled decolonization actions, all adverse events during decolonization and surgery, and two questions regarding the comprehension of the science (indication for decolonization, potential benefit expected in the individual case).~The questionnaire is handmade and validated by the Investigators."

Trial Locations (2)

8008

Balgrist University Hospital, Zurich

Unknown

Balgrist University Hospital, Zurich

All Listed Sponsors
collaborator

Industry (Schülke & Mayr AG, Switzerland and Germany)

UNKNOWN

lead

Balgrist University Hospital

OTHER

NCT05647252 - General Decolonization With Octenisan® Set Before Elective Orthopedic Surgery | Biotech Hunter | Biotech Hunter